KEGG gene set enrichment analysis found that meningiomas with NF2 inactivation are enriched for “pathways in cancer”, indicating the susceptibility of NF2 meningiomas to undergo further aggressive evolution (Figure 1D, left panel). The gene discussed is NF2; the disease is meningioma.